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GC–MS-based urinary organic 
acid profiling reveals multiple 
dysregulated metabolic pathways 
following experimental acute 
alcohol consumption
Cindy Irwin1, Lodewyk J. Mienie1, Ron A. Wevers  2, Shayne Mason1, Johan A. Westerhuis  1,3, 
Mari van Reenen4 & Carolus J. Reinecke1
Metabolomics studies of diseases associated with chronic alcohol consumption provide compelling 
evidence of several perturbed metabolic pathways. Moreover, the holistic approach of such studies 
gives insights into the pathophysiological risk factors associated with chronic alcohol-induced disability, 
morbidity and mortality. Here, we report on a GC–MS-based organic acid profiling study on acute 
alcohol consumption. Our investigation — involving 12 healthy, moderate-drinking young men — 
simulated a single binge drinking event, and indicated its metabolic consequences. We generated time-
dependent data that predicted the metabolic pathophysiology of the alcohol intervention. Multivariate 
statistical modelling was applied to the longitudinal data of 120 biologically relevant organic acids, 
of which 13 provided statistical evidence of the alcohol effect. The known alcohol-induced increased 
NADH:NAD+ ratio in the cytosol of hepatocytes contributed to the global dysregulation of several 
metabolic reactions of glycolysis, ketogenesis, the Krebs cycle and gluconeogenesis. The significant 
presence of 2-hydroxyisobutyric acid supports the emerging paradigm that this compound is an 
important endogenous metabolite. Its metabolic origin remains elusive, but recent evidence indicated 
2-hydroxyisobutyrylation as a novel regulatory modifier of histones. Metabolomics has thus opened an 
avenue for further research on the reprogramming of metabolic pathways and epigenetic networks in 
relation to the severe effects of alcohol consumption.
Notwithstanding the encyclopaedic information on alcoholism, the WHO asserts that alcohol remains one of the 
world’s leading risk factors for disability, morbidity and mortality — 5.9% of all deaths worldwide are attributable 
to alcohol consumption, exceeding those from HIV/AIDS (2.8%), violence (0.9%) or tuberculosis (1.7%)1. The 
tenth edition of the International Classification of Diseases lists at least 25 chronic conditions that are entirely 
attributable to alcohol; alcohol is also a risk factor in certain cancers, some tumours, numerous cardiovascu-
lar and digestive diseases, and many neuropsychiatric conditions2. Brain image studies have revealed changes 
in brain structure during the progression from adolescence to adulthood3,4, a critical period characterized by 
increased brain connectivity and maturation of brain neural circuits. These changes are highly susceptible to 
the effects of exogenous substances, which likely include alcohol5–7, making children and adolescents especially 
vulnerable to alcohol-related harm8. It was reported from a recent survey that approximately 50% of children 
(aged 11–14 years) in the UK have consumed alcohol, and 33% of adolescents (15–16 years) admitted to having 
experienced at least one episode of acute alcohol intoxication in the month preceding the survey9.
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Human genome-wide association studies (GWAS) have identified polymorphisms and candidate genes 
associated with individuals’ innate risks for alcohol dependence10–12. With metabolomics involving large-scale 
molecular studies of metabolic systems, it provides novel and complementary approaches to GWAS studies13–15. 
Additionally, metabolomics has revealed the extensive perturbations of various metabolic pathways in response to 
chronic alcohol consumption, which underpin alcohol-induced disease states. Such studies show much promise 
for disease profiling and biomarker identification of the conditions associated with and arising from chronic alco-
hol consumption16. The burden attributable to acute alcohol consumption (rapid ingestion of alcoholic beverages) 
or binge drinking (drinking too much too fast) has been shown to be similarly high17–19. Impediments associated 
with acute and binge drinking include perturbed metabolism (e.g. glycogen depletion, acidosis and hypoglycae-
mia)20, damage to intestinal epithelial cells21, neurobiological diseases22, and ultimately even abrupt premature 
death due to physical or mental disabilities23,24.
Several important observations on acute alcohol consumption have recently been obtained from animal-based 
studies:
 1. A rodent “intragastric feeding model” was investigated with ultra-high performance liquid chromatog-
raphy-time of flight mass spectrometry (UHPLC-TOFMS) technology to determine changes in global 
metabolite profiles for plasma and urine from alcohol treated rats and mice compared to control animals25. 
Apart from several other observations, the researchers reported changes in the concentrations of 5-hydrox-
ytryptophan and xanthurenic acid, both of which are intermediates in tryptophan metabolism. These ob-
servations provide further insight into the association of liver metabolism in response to ethanol exposure.
 2. A study on the immune response of healthy individuals (11 males and 14 females, aged 21–56 years) with 
no history of alcohol use disorder, revealed that acute binge drinking resulted in a rapid increase in serum 
Gram-negative bacterial endotoxin lipopolysaccharide (LPS) and bacterial 16S rDNA. LPS is a potent 
trigger of the inflammatory cascade via activation of the Toll-like receptor 4 (TLR4) complex and increase 
in the portal and/or systemic circulation in several types of chronic liver diseases26. The elevation of bac-
terial 16 S rDNA levels after acute binge drinking indicated transient gut-derived microbial translocation 
as a likely mechanism for the serum LPS increase. The authors suggest that the increased serum levels of 
bacterial products following acute consumption might contribute to innate immune responses and poten-
tially to the behavioural effects associated with alcohol binge drinking. The study also draws attention to 
potential perturbations in metabolite profiles which may be due to the role of the gut and the microbiome 
in binge drinking. This point is substantiated by GC–MS urinary metabolomics results from another study, 
which revealed metabolite differences between Sprague–Dawley and Wistar rats following different pertur-
bations, including consecutive acute ethanol interventions27. These results directed to different metabolic 
pathways and differences in the intrinsic metabolism and symbiotic gut microflora between these animal 
strains.
 3. A review of the analytical technologies used in profiling studies of animal or human serum, plasma, urine 
and tissue samples, obtained following exposure to alcohol, summarizes a range of endogenous metabolites 
that have been proposed as potential ethanol consumption-related biomarkers28. This range of biomarkers 
provides biochemical insights that are essential for understanding the effects and mechanisms of ethanol 
toxicity.
Notwithstanding the potential of metabolic profiling, a recent review noted that few studies on acute alco-
hol consumption have been undertaken in humans29, recognizing that these models could provide a basis for 
studying the biochemical effects of prolonged ethanol exposure, as well as to potentially identify biomarkers for 
monitoring the progression of alcoholism in man25.
We thus postulated that our metabolomics approach could provide further insights into the metabolic sig-
nature which arises from a single excessive dose of alcohol. However, the response to experimental alcohol con-
sumption is complex, as shown by the diverse observations noted from the study on two related animal strains27. 
Alcohol studies in humans, likewise, vary greatly according to the extent and method of usage (chronic or acute), 
individual variability (genetic and behavioural), and environmental factors. Also, individuals’ attitude to their 
consumption habits is a private issue, and important ethical considerations (such as restricted case participation 
and policy guidelines) have to be taken into account during the selection of sufficient and appropriate participants 
for the laboratory assessment of alcohol use30. Therefore, recording the influence of alcohol in laboratory studies 
involving a select group of moderate-drinking young men, as we present here, is complex from several points of 
view.
Despite these limitations and qualifications, the application of metabolomics to intervention or challenge 
studies is a preferred practical approach towards a holistic understanding of the effects of consumed substances 
on metabolism31,32. Intervention studies produce extensive data sets due to longitudinal (time-dependent), 
multi-subject (several experimental participants), multi-group (number of interventions), and multivariate data 
(numerous metabolic variables) inputs33,34. Our previous intervention study on consuming commercial flavoured 
water with a benzoic acid preservative35 indicated that time-dependent metabolomics investigations, using 
designed interventions, provide a way of interpreting the variation induced by the different factors of a designed 
experiment. This approach has the potential to significantly further our understanding of normal and patho-
physiological perturbations of endogenous or exogenous origin. Here we report on a metabolomics study which 
used commercial flavoured water as a vehicle35 for vodka consumption, to simulate acute but controlled alcohol 
consumption (resembling a single incident of acute or binge drinking) in young male participants. All metabo-
lomics studies are inherently hampered by an analytical inadequacy to provide a comprehensive coverage of the 
metabolome. Given the known main pathways of alcohol metabolism, we selected a gas chromatographic–mass 
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spectrometric (GC–MS) approach to analyse the urinary samples collected during this time-dependent cross-over 
study. These analyses generated an extensive data set, from which (by using conventional and extended statistical 
methods) we could reveal a multitude of disturbances in the urinary organic acid profiles over time due to the 
alcohol intervention.
Results
Effect of the acute alcohol intervention across all cases. Observations of the behaviour of the partic-
ipants during the intervention stage indicated a moderate degree of acute alcohol consumption characteristic of 
the early phase of a binge-drinking event by young male students36. To determine the effect of the alcohol inter-
vention, the data sets of 120 organic acid metabolites, generated from the samples collected at times 1, 2, 3 and 
4 hours following the intervention, were compared with the data set from the samples collected prior to the inter-
vention (time 0), and presented for unsupervised principal component analysis (PCA) (Fig. 1a–d). Subsequently, 
a supervised partial least squares discriminant analysis (PLS–DA) was performed to maximize the discrimination 
between the controls (time 0) and the subsequent hourly-collected data. The PCA scores plots showed some 
differentiation 1 hour after the alcohol consumption (Fig. 1a), followed by complete separation after 2 hours, and 
a progressive return to the time 0 profile after 3 and 4 hours. The PLS–DA scores plots (Fig. 1e–h) showed a com-
plete separation for all four times following alcohol consumption relative to time 0.
For better insight into the time effect of the intervention, two complementary approaches were used, both 
of which are founded on Principal Component Analysis (PCA). The first, ANOVA Simultaneous Component 
Analysis (or ASCA), enabled us to partition variation similar to an analysis of variance (or ANOVA) approach 
using the experimental design, and summarize variation observed across many variables through projection to 
a lower dimensional space. The scores plot resulting from the ASCA model (Fig. 2a) indicates a marked change 
one hour after the intervention. After 3 hours a state of homeostasis is reached as indicated by the similarity 
between times 3 and 4. This is, however, a new state of homeostasis, since it is not comparable to the state prior 
to the intervention, as will be discussed below. Though time 2 appears to show a larger perturbation compared to 
time 1, following the intervention, time 2 also shows a progression towards the new state of homeostasis, making 
it less indicative of the initial alcohol effect. The ASCA model partitioned variation from various sources in the 
design (that is, time and participant) by averaging out individual effects. Secondly, performing PCA on the data-
set unfolded in time provides another view on the variation observed, which ties repeated observations together 
into a single profile. The scores from such a model provide a complimentary and, in a sense, confirmatory sum-
mary of the effect of the alcohol consumption in time, as indicated by the score centroids shown in Fig. 2b. It is 
evident that there was a change in the organic acid profile (i.e. across all cases) over time, with the most extensive 
change visible 1 hour (time 1) after the intervention. The centroids plotted for times 2 to 4 complement the inter-
pretation made from the ASCA.
Based on the statistical criteria, a total of 13 variables (Table 1) were identified as those responsible for the sep-
aration between the control samples and those collected one hour after alcohol consumption. Shown in Table 1 
are the VIP values, p-values and FC values at time 1 relative to time 0, as well as the mean and standard deviation 
values for all times. The FC and p-values for time 4 relative to time 0 are also included to show the eventual dimin-
ishing effect of the alcohol on the 13 metabolites. In addition, since ethanol data is essential in the context of this 
Figure 1. PCA and PLS–DA scores plots following alcohol consumption. Input data were from the 120 
quantified metabolites for time 0 vs time 1 (a,e), time 0 vs time 2 (b,f), time 0 vs time 3 (c,g), and time 0 vs time 
4 (d,h) following alcohol consumption. The samples for time 0 were collected just prior to the intervention, and 
are therefore regarded as the control samples. The figures were based on the non-paired method of analysis. 
Results from the paired method are shown in Supplementary Fig. S2.
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intervention study, these values are included for reference purposes. However, ethanol cannot be reliably detected 
with the GC–MS method used here, and therefore the quoted urinary ethanol values were measured through a 
targeted proton nuclear magnetic resonance [1H-NMR] spectroscopy analysis. The full metabolite profile that 
became apparent through this NMR metabolomics study will be reported in a subsequent paper.
Consumed ethanol is known to be dispersed through exhaling (not measured), metabolic conversions and 
urinary excretion, which peaked at two hours following its consumption (Table 1). However, the results from 
the ASCA and unfolded PCA (Fig. 2) — which indicated that the most dramatic metabolite changes occurred 
one hour following the intervention — encouraged us to preferably study in detail the metabolic effects seen one 
hour after alcohol consumption. Of the important metabolites, hippuric acid, the phase II biotransformation 
product of benzoic acid27,35–38, had the highest VIP value (Table 1, VIP = 19.6). The concentration of hippuric acid 
was already high at time 0 (948 μmol/mmol Cr), due to its being the normal excretion product of benzoic acid 
derived from the gut microbiome. This concentration increased to 3037 μmol/mmol Cr one hour after the alcohol 
consumption, owing to the benzoic acid preservative in the flavoured water vehicle consumed with the alcohol. 
Hippuric acid likewise appeared to be the most important discriminating variable in the previously described 
effects of the vehicle-only intervention35, as well as in the consecutive acute ethanol intervention study on rats, 
where the change in urinary hippuric acid is suggested to be due to a metabolic dysfunction of damaged liver 
tissue27. The presence of the high concentration of hippuric acid does not influence the outcome of the analysis, 
since the same list of important metabolites (VIP > 1.0) is obtained after excluding hippuric acid from the data 
(see section 4.6 of the SI). It is also worth noting that four other gut-related urinary metabolites observed in the 
rat study27 were also present in the urine samples from our study (see Supplementary Table S2 in section 3 of 
the SI), but did not appear to be discriminatory metabolites due to the alcohol intervention. Other important 
biotransformation products from the rat and mouse intervention studies, such as ethyl glucuronide and ethyl 
sulphate25, were not detectable by the GC–MS methods used in the present study.
The metabolic interrelations among the remaining 12 metabolites in Table 1 correspond to several meta-
bolic consequences of alcohol consumption. The oxidation of ethanol by alcohol dehydrogenase (ADH) creates a 
highly reduced cytosolic environment in hepatocytes, and favours the production of lactic acid (second-highest 
VIP) from pyruvic acid, resulting in downstream metabolic consequences due to pyruvic acid depletion. 
The reduced environment also accounts for the perturbations observed for vanillylmandelic (FC = −1.6), 
2-hydroxybutyric (FC = +4.3) and 3-hydroxybutyric (FC = +5.9) acids, and increased urinary excretion of suc-
cinic, fumaric, malic and 2-hydroxyglutaric (derived from 2-ketoglutaric acid) acids that implicates a dysfunc-
tional Krebs cycle. Increased excretion of N-tiglylglycine (the phase II biotransformation product of tiglyl-CoA) 
and 2-ethylhydracrylic acid (intermediates in the R- and S-pathways of isoleucine catabolism, respectively), as 
well as 3-hydroxyisobutyric acid (produced from valine catabolism) points to amino acid mobilization but inhi-
bition of gluconeogenesis39. The reason for the increased excretion of 2-hydroxyisobutyric acid (2-HIBA) remains 
speculative and will be discussed below.
To characterize the metabolic relationship between the 13 important variables further, we calculated 
Spearman’s rho correlation coefficients over the full period of the alcohol intervention, as described in section 4.4 
of the Supplementary Information (SI), and shown in Fig. 3.
Important observations from the correlation analysis correspond to the metabolic interrelations: (1) the profile 
for vanillylmandelic acid was unique — it was the only metabolite that showed a negative correlation with time 
(r = −0.7), indicating that its urinary concentration constantly decreased over the study period, and remained 
very low (1.75 μmol/mmol Cr; p = 0.034; FC = −8.8) towards the end (at time 4 hours). (2) A good correlation 
(r = 0.4 to 0.7) was observed between the indicators of ketosis (lactic, 2-hydroxybutyric and 3-hydroxybutyric 
Figure 2. Multivariate approaches to indicate the time effect. (a) ASCA scores on the first three latent variables 
(LV1 to LV3), along with 95% confidence ellipsoids for the centroids, are shown and colour-coded according 
to time following the intervention (0, 1, 2, 3 and 4 hours shown in black, red, pink, dark blue and light blue, 
respectively), with the arrow showing the time-dependent trend, using the same discriminating colour 
sequence. (b) Unfolded PCA scores centroids for each time point based on the first two principle components 
(PC1 and PC2) are shown. The colours of the centroids are the same as for the ASCA and the direction of the 
trajectory is indicated by the red arrows, starting from time 0.
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acids), but only in the initial phase following alcohol consumption, as indicated by their neutral correlations with 
time (r = 0 to −0.2 with time). (3) A high to very high correlation (r = 0.6 to 0.8) was observed between the Krebs 
cycle-associated metabolites, all of which also show a reasonable correlation (r = 0.3 to 0.5) over the full period 
following the intervention. (4) Likewise, N-tiglylglycine showed a high correlation with the Krebs cycle interme-
diates (r = 0.6 to 0.8), which also extended over the full study period (r = 0.7).
The high correlation values shown in Fig. 3 collectively substantiate a strong interrelationship between the 
13 organic acid metabolites that were regarded as important due to acute alcohol consumption. The mean con-
centrations, and the time 4 relative to time 0 p-values ([WRT]0–4) and fold changes ([FC]0–4) for the 13 variables 
(listed in Table 1), support the conclusions about the individual and group correlations observed in Fig. 3; they 
also provide an alternative and additional support for the observations from the correlation study.
Inter-individual variation following acute alcohol consumption. In order to illustrate the 
inter-individual variation between the participants, as well as the longitudinal effect of the alcohol consumption, 
PCA of the data unfolded in time was performed as described in section 4.5 of the SI. The unfolding transformed 
the three-dimensional data (a tensor of cases, interventions and time) into a two-dimensional matrix, and thus 
allowed PCA to account for the longitudinally repeated measures.
Figure 4a–c illustrates the scores based on the first two principal components (PC1 and PC2) of the PCA 
model. This analysis of the unfolded data provides insight into the effect of the acute alcohol consumption over 
time on the 120 metabolites. The centroids of the PCA scores for each time (Fig. 4a), as well as those of two indi-
vidual cases (Fig. 4b,c), illustrate the inter-individual variation in response to the intervention. The averaged and 
individual trajectories showed similarities in the individual responses to the alcohol consumption over time, since 
they all indicated a biphasic response pattern (phase 1: times 0 to 1 to 2, and phase 2: times 2 to 3 to 4). However, 
distinct differences were also noted, indicated by the unique orientation and biphasic profiles of the trajectories of 
the individuals (Fig. 4b,c). The metabolic basis for the latter observation is illustrated, for example, by a compar-
ison of the lactic acid excretion observed in the two cases, which progressed from 8.2 to 6.0, 74.5, 14.7 and 16.0 
μmol/mmol Cr for case 1 (Fig. 4b), but from 10.6 to 31.2, 19.8, 8.7 and 11.2 μmol/mmol Cr for case 2 (Fig. 4c). 
Metabolitesa
PLS–DA 
VIP ≥ 1.0 
(Controls 
vs 1 hr)
[WRT]0−1 [FC]0−1
Mean concentrations of metabolites [Std. Dev.] μmol 
metabolite/mmol Cr [WRT]0−4 [FC]0−4 HMDB Ref. values μmol 
metabolite/
mmol Cr
Summary statistics 
(Controls vs 1 hr) t = 0 t = 1 t = 2 t = 3 t = 4 hr
Summary statistics 
(Controls vs 4 hr)
Hippuric acid 19.6 0.002 +3.2 948[737]
3037
[1357]
2775
[2051]
1157
[1111]
726
[764] 0.239 −1.3 27.9–932.7
Lactic acid 14.4 0.015 +27.4 8.73[3.65]
239
[412]
28.1
[19.7]
15.5
[14.7]
12.1
[8.51] 0.209 +1.4 3.9–9.8
Fumaric acid 7.24 0.003 +6.4 0.78[0.47]
4.96
[4.53]
5.88
[6.08]
2.62
[1.94]
2.8
[2.15] 0.006 +3.6 0.75–1.2
Vanillylmandelic acid 5.03 0.034 −1.6 15.4[3.61]
9.87
[7.39]
2.96
[2.32]
1.87
[1.11]
1.75
[0.99] 0.002 –8.8 1.1–1.7
2-Hydroxybutyric acid 4.06 0.034 +4.3 2.68[1.54]
11.4
[16.0]
3.85
[2.68]
2.26
[1.16]
2.52
[2.15] 0.695 −1.1 1.2–6.9
Succinic acid 3.88 0.010 +2.6 3.81[3.81]
9.83
[7.90]
20.2
[24.6]
12.8
[12.8]
12.7
[12.3] 0.004 +3.3 4.9–14.9
3-Hydroxybutyric acid 2.76 0.041 +5.9 0.40[0.54]
2.39
[2.96]
0.59
[0.55]
0.47
[0.40]
0.77
[0.68] 0.182 +1.9 1.4–2.2
2-Ethylhydracrylic acid 1.66 0.010 +2.1 1.09[1.00]
2.30
[1.73]
2.53
[2.78]
1.76
[1.61]
1.86
[1.47] 0.015 +1.7 1.3–2.9
3-Hydroxyisobutyric acid 1.56 0.034 +1.9 3.01[1.27]
5.76
[3.86]
3.31
[2.05]
2.74
[1.25]
3.44
[1.95] 0.239 +1.1 4.1–19.0
2-Hydroxyisobutyric acid 1.39 0.034 +1.8 11.1[4.03]
20.5
[14.2]
20.5
[13.4]
12.8
[6.93]
16.3
[13.1] 0.209 +1.5 4.4–7.6
Malic acid 1.32 0.023 +4.9 0.27[0.16]
1.30
[1.60]
1.81
[1.59]
0.86
[0.67]
1.19
[1.37] 0.006 +4.5 0.7–5.3
N-Tiglylglycine 1.22 0.034 +1.7 1.55[1.15]
2.65
[1.39]
10.9
[9.15]
10.9
[9.35]
10.8
[8.64] 0.002 +7.0 0.78–1.2
2-Hydroxyglutaric acid 1.06 0.023 +1.7 2.88[0.99]
4.91
[3.39]
10.0
[5.90]
7.22
[3.62]
8.50
[5.73] 0.003 +3.0 0.8–52.0
Ethanolb n/a n/a n/a 0.0 1368 5173 2852 1810 n/a n/a n/a
Table 1. Univariate, multivariate and descriptive statistics for the most perturbed metabolites following alcohol 
consumption. A total of 13 organic acid metabolites were identified as important discriminatory variables one 
hour after alcohol consumption (VIP ≥ 1.0, p ≤ 0.05 and |FC| ≥ 1.5). Abbreviations used: [Std. Dev.], standard 
deviation; Cr, urinary creatinine value; HMDB, Human Metabolome Database; [WRT]0–1 and [WRT]0–4, 
Wilcoxon signed-rank test p-values showing the significance of a metabolite at times 1 and 4 hours relative to 
time 0; [FC]0–1 and [FC]0–4, fold change values for a metabolite at times 1 and 4 hours relative to time 0; n/a, not 
applicable for the purpose of this table. a13 organic acid metabolites (concentrations expressed as μmol/mmol 
Cr), identified through GC–MS analysis. bEthanol (concentrations expressed as μmol/mmol Cr), identified 
through an independent, targeted 1H-NMR analysis of the same urine samples as used for the GC–MS analyses.
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Similar differences in the individual responses to the alcohol consumption were observed for several other metab-
olites as well, which cumulatively result in the unique trajectory of each individual subject — an observation that 
agrees with the contemporary view on genetic and metabolic individuality.
Figure 4d–f illustrates the bi-plots for the top most influential metabolites responsible for the separation 
in the unfolding of the PCAs. The dominant metabolites observed at time 0 were phase II biotransformation 
products (hippuric acid and phenylacetylglutamine) and organic acids originating from the gut microbiome 
(4-hydroxyphenylacetic, indole-3-acetic, pyrrole-2-carboxylic and pyroglutamic acids). This gut-derived organic 
acid profile dominates at all the times measured, as also indicated in Figs. 4e,f for times 1 and 4 hours. Notably, 
one hour after alcohol consumption, lactic, 2-hydroxybutyric and fumaric acids appear as additional impor-
tant metabolites, in accordance with the results in Table 1 and Fig. 3. At time 3, aconitic acid is indicated as an 
important metabolite (figure not shown), whereas N-cinnamoylglycine and glucoronic acid (both associated with 
phase II biotransformation) appear to be important 4 hours after alcohol consumption. It thus appears that the 
endogenous detoxification mechanisms through biotransformation remained functional despite the acute alcohol 
consumption.
Discussion
In this study, the metabolomics organic acid profile revealed significant metabolic effects of a single dose of 
alcohol, consumed in a well-defined vehicle by healthy, moderate-drinking males. Although their analytical con-
straints limit the scope of profiling studies, we concur with the view that carefully conducted studies in humans 
are warranted, and would provide valuable new insights into the short and long term effects of alcohol exposure, 
alcoholic liver disease and alcoholism, in man28. The method followed here offered a convenient and sensitive 
approach to uncover perturbed metabolic pathways, of which we modelled the main ones as illustrated in Fig. 5. 
Several distinct insights deserve special attention.
The first insight deals with hepatic robustness. Glycine N-acyltransferase (GLYAT)-based biotransforma-
tion was shown to play a vital background role during the intervention study. The scores and bi-plots from the 
unfolded PCAs (Fig. 4d–f) revealed the reasons for the observed differentiation between the groups shown in 
the scores plots of the unsupervised PCAs (Fig. 1a–d). The observed differentiation was caused primarily by 
detoxification (gut metabolites) and biotransformation (phase II conjugates) processes. Apart from the alcohol 
load from the intervention, the liver is simultaneously confronted with the benzoic acid load from the vehi-
cle, which induced a significant hepatic biotransformation response35. Two closely related acyl-CoA:amino 
acid N-acyltransferases have been characterized as operative in liver mitochondria40. One transferase was spe-
cific for benzoyl-CoA, salicyl-CoA, and certain short straight- and branched-chain fatty acyl-CoA esters as 
substrates, whereas the other enzyme specifically used either phenylacetyl-CoA or indoleacetyl-CoA. It thus 
Figure 3. Correlation matrix over the full time period for the 13 metabolites listed in Table 1. Correlations 
extend from high positive (red; r ≥ 0.6) through neutral (green; −0.2 < r < 0.2) to high negative (blue; r ≤ −0.6). 
The high correlation between lactic, 2-hydroxybutyric and 3-hydroxybutyric acids and the high correlation 
between the Krebs cycle-associated metabolites (together with their respective time slots) are blocked in green 
and orange, respectively.
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seems probable that the benzoyl-CoA:glycine N-acyltransferase (using glycine as the preferred acyl acceptor) 
was functional in the biotransformation of the vehicle-induced accumulated benzoyl-CoA, but notably also of 
tiglyl-CoA and 2-methylenebutyryl-CoA, which accumulated from perturbations due to the alcohol consump-
tion. This biotransformation resulted in the formation and increased excretion of hippuric acid, N-tiglylglycine 
and N2-methylenebutyrylglycine (a minor metabolite increased due to the alcohol consumption — data not 
shown, but included in Fig. 5), respectively. The metabolomics approach thus provides insight into a background 
process that underscores the robustness of hepatic function in healthy individuals, notwithstanding the impact 
of the acute alcohol consumption — an observation that would not hold true for the liver affected by chronic 
alcoholism.
The second insight deals with the comprehensive metabolic perturbations caused by the acute alcohol con-
sumption, as disclosed by the supervised PLS–DA. The metabolic reactions following alcohol consumption 
showed a phased response profile, to which the gut is known to contribute following alcohol consumption. In 
the early phase, a fraction of the alcohol consumed orally may be immediately metabolized by the gut alcohol 
dehydrogenase (ADH) isoforms in a process known as first-pass metabolism41. A study on acute alcohol binge 
drinking showed increased serum levels of bacterial products (endotoxin and bacterial 16S rDNA) derived from 
the gut microbiome42. The serum endotoxin levels rapidly increased within 30 minutes following consumption, 
remained elevated for 3 hours and returned to lower than baseline levels by 24 hours after alcohol intake. The early 
increase in 2-hydroxybutyric acid following alcohol consumption observed in the present study (Table 1, Figs 3 
and 4e metabolite 8) is an indication of a limited contribution from first-pass metabolism in the present exper-
imental group: threonine is anticipated to be produced from the increased intestinal acetaldehyde (the product 
of ethanol metabolism), and is subsequently catabolised in the liver to 2-hydroxybutyric acid, as proposed in the 
representation shown in Fig. 5. However, since the liver is important in alcohol metabolism, and considering its 
wide spectrum of lesions43, we linked most of the metabolomic perturbations observed in the present study to 
the liver metabolism, as shown in the conceptual model in Fig. 5. Alcohol oxidation by hepatic ADH results in 
the reduction of NAD+ to NADH, thereby generating a highly reduced cytosolic environment in hepatocytes. 
The increased NADH:NAD+ ratio influences the acetaldehyde–lactate dehydrogenase coupled lactic acid accu-
mulation (ALDH–LDH = EC1.2.1.10–EC1.1.1.27). Greatly increased lactic acid excretion (Table 1, Figs 3 and 4e 
metabolite 7) is proposed as the next early hallmark of acute alcohol consumption and, together with the 
Figure 4. Unfolded PCA scores and selected bi-plots. (a) PC1 and PC2 of the mean of the cases studied 
are shown (in red), as well as the 90% confidence ellipsoids for scores of PC1 and PC2 at time 0, 1, 2, 3 and 
4 hours. The centroids of the five time-dependent clusters are indicated as red squares. The direction of the 
trajectory linking the centroids from time 0 onwards is indicated by a black arrow. (b) and (c) The trajectories 
of the spectral profiles of two individual cases, illustrating the variation in the averaged profiles in response 
to the alcohol intervention. (d–f) Bi-plots showing the seven most important metabolites when ranking was 
based on the sum of the squares of loadings of the first two components. These metabolites are more primarily 
responsible for the pattern in the plot, that is, causing separation in the unfolding of the PCAs, as applicable 
for times 0 (d), 1 hour (e) and 4 hours (f). Encircled numbers identify the metabolites: 1, hippuric acid; 2, 
phenylacetylglutamine; 3, 4-hydroxyphenylacetic acid; 4, indole-3-acetic acid; 5, pyrrole-2-carboxylic acid; 
6, pyroglutamic acid; 7, lactic acid; 8, 2-hydroxybutyric acid; 9, fumaric acid; 10, N-cinnamoylglycine; 11, 
glucuronic acid.
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concomitant early increase in 3-hydroxybutyric acid (Table 1 and Fig. 3), is linked to ketogenesis. Acetoacetic 
acid, the precursor of 3-hydroxybutyric acid, showed a similar early increase (0.012, 0.016 and 0.044 μmol/mmol 
Cr at times 0, 1 and 2 hours, respectively), and peaked at two hours after alcohol consumption (VIP = 0.004; 
FC = 3.64; p = 0.02).Taken together, first-pass metabolism and ketogenesis seem to be the immediate salvage 
responses to disturbed homeostasis caused by the acute alcohol consumption.
Further, an increased NADH:NAD+ ratio (depleted NAD+) has been described to influence the direction of 
several metabolic processes, including decreased glycolysis44, decreased Krebs cycle20,45, and decreased gluco-
neogenesis20,46. The early increase in fumaric acid (Table 1, Figs 3 and 4e metabolite 9) indicates reduced Krebs 
cycle functionality, which persisted to the end of the 4-hour period of the present intervention study (Table 1 
and Fig. 3). The notable and persistently reduced Krebs cycle functionality is further supported by the inhi-
bition of the catabolism of all three branched-chain amino acids, indicated by the profiles of N-tiglylglycine, 
2-ethylhydracrylic acid and 3-hydroxyisobutyric acid (Table 1 and Fig. 3). It is worth noting that the perturbed 
urinary metabolite profile had not normalized 4 hours after alcohol consumption, although the supervising phy-
sician regarded the participants sufficiently sober to permit them to leave the clinic at this time.
The third insight highlights the observations on vanillylmandelic acid. This metabolite was significantly 
down-regulated by depleted NAD+, and remained so over the full 4-hour period (Table 1 and Fig. 3). The 
down-regulation of vanillylmandelic acid reflects the upstream inhibition in the catabolism of the catecho-
lamines noradrenaline and adrenaline, which occurs due to the inhibition of the NAD+-dependent aldehyde 
dehydrogenase-catalysed reactions (EC1.2.1.3 and EC1.2.1.5, respectively). The known relative rise in adrena-
line and the delayed increase in noradrenaline concentrations after alcohol consumption is a physiological effect 
of the inhibition of these enzymes47, which, together with the corticotrophin-releasing factor, may contribute 
to negative affective states and relapse vulnerability during alcohol abstinence48. The observations on vanillyl-
mandelic acid may also be important for other alcohol related studies. In a study on alcoholic patients, higher 
levels of urinary homovanillic acid (an up-stream metabolite of the catecholamine pathway) were observed in 
patients with a A1 allele in their genotype, when compared to patients homozygous for the TaqIA2 allele49. We 
observed that homovanillic acid peaked two hours after acute alcohol consumption (VIP = 0.129; FC = 1.13; 
p 0.44). These findings suggest that determination of urinary levels of catecholamine end-products should be 
Figure 5. Proposed model indicating some important metabolic pathways affected by acute alcohol 
consumption. Up- or down-regulated metabolites are shown in red. Abbreviations used: MCT, monocarboxylic 
acid transporter; four-figure numbers (e.g. 2.6.1.42) refer to the IUBMB enzyme nomenclature (EC number); S, 
main catabolic pathway of isoleucine; R, minor catabolic pathway of isoleucine, which may act as a safety valve 
for overflow of accumulating metabolites from the S-pathway. Credit for images used: Kidney – ID 20446327 © 
Natis76 | Dreamstime.com; Muscle – ID 69693231 © Tigatelu | Dreamstime.com; Liver & Digestive system – ID 
43552467 © Bluezace | Dreamstime.com.
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included in alcohol-related studies, since variance in their levels could relate to a polymorphism, and could affect 
addictive behaviour.
As a last insight, 2-hydroxyisobutyric acid (2-HIBA) was indicated in this study to be an important and 
significant organic acid indicator regarding the metabolic consequences of acute alcohol consumption. 
2-Hydroxybutyric acid and 2-HIBA are normally reabsorbed in the kidney by a monocarboxylic acid transporter 
(MCT). This transporter is, however, also responsible for transporting lactic acid between the urine and the 
blood. After alcohol consumption, the increased lactic acid contributes to the saturation of these transporters. 
Consequently, not all of the 2-hydroxybutyric acid and 2-HIBA is reabsorbed, leading to their increased excre-
tion in the urine. However, the conventional view is that urinary 2-HIBA is a non-metabolite, obtained from 
environmental exposure to tertiary-butylacetate (a commercial solvent used in industrial coatings and cleaners) 
and certain gasoline additives50–52. But things change. New research casts a valuable light on 2-HIBA, suggesting 
that it appears to be an important metabolite with potential value for health and disease — 2-HIBA is reported 
to be up-regulated in known human disorders such as chronic kidney disease53, diabetes mellitus54,55, human 
gastric cancer56, fibromyalgia57, myocardial infarction58–60, and a number of inborn errors of metabolism61,62. In 
the present study, alcohol induced significant up-regulation of 2-HIBA in the first two hours after consumption 
(Table 1: VIP = 1.39; FC = +1.8; p = 0.034). The very high correlation of 2-HIBA with lactic acid (r = 0.8), and 
high correlation with 2-hydroxybutyric and fumaric acids (r = 0.6), strongly supports the view that 2-HIBA is an 
endogenous metabolite. However, considering the diversity of the conditions associated with the up-regulation 
of 2-HIBA, a common metabolic origin remains elusive. Most notably, MS analyses of peptide fragments from 
human histones recently identified a new type of histone mark, namely lysine 2-hydroxyisobutyrylation, which 
is conserved, widely distributed, has a high stoichiometry, and induces large structural change in histones63. 
Histone acetylation was first identified more than 50 years ago64, and has since become known as wide-ranging 
posttranslational modifications, linked to a variety of processes, including transcription, DNA replication, and 
DNA damage. A comprehensive catalogue of histone modifications and their proposed functional consequences65 
includes 2-hydroxyisobutyrylation of lysine side chains, amongst others, for which a rather limited function has 
been determined. Histone modifications are proposed to present a large opportunity in the years to come to gain 
insights into chromatin biology, epigenetic events and their biological consequences, which should include the 
proposed alcoholism-related involvement of 2-HIBA66 in the modification of histones67,68.
Metabolomics studies, however, have limitations: (1) GC–MS analysis, our method of choice, produces data 
that are noisier than other metabolomics data types, such as NMR or triple quadrupole liquid chromatography–
mass spectrometry (LC–QQQ–MS). This may be overcome by using more experimental subjects (but their num-
ber was limited in this study due to ethical considerations), or by using replicates of all samples (rather than only 
random repeat samples as used in our measurement design). (2) Although it would be useful, quantifying metab-
olomics data absolutely is often difficult to execute accurately, is relatively expensive, and is rarely done in diag-
nostic or intervention study designs as presented here. As an acceptable alternative, therefore, we expressed our 
metabolite concentrations as values relative to an internal standard. (3) Concomitant plasma or serum analyses 
did not form part of this experimental design. Therefore, the metabolomic variables considered in this investiga-
tion were generated from only organic acid analyses of urine samples, and were modelled on theoretical grounds 
on metabolic pathways of the gut, muscle and liver (Fig. 5). Given the intoxicating influence of alcohol, metabolite 
levels in the brain are also important, but could also not be considered here due to the biofluid used. However, as 
baseline, the perturbations of urinary organic acid profiles provide a prime and feasible way for clinical tests to 
screen for individual response types, as well as for other relevant aspects of acute alcohol exposure.
Conclusions
Taken together, our findings indicate that metabolomics provided a systematic and standardized method for 
detecting a range of metabolic responses over time, not previously described comprehensively for acute alcohol 
consumption. These findings open avenues for potentially important future investigations in alcohol research: 
(1) genotype-based selection of individuals in follow-up alcohol intervention studies is advised, given the clear 
inter-individual responses to alcohol consumption; (2) low values of urinary vanillylmandelic acid may be an 
indicator of a binge drinking or acute alcohol consumption episode in seemingly non-intoxicated individuals; 
and (3) the striking presence of 2-HIBA supports the emerging new paradigm of 2-HIBA being an important 
endogenous metabolite. Moreover, detailed studies on the biological origin of 2-HIBA, as well as on its per-
ceived gene-modification role through lysine 2-hydroxyisobutyrylation of histones may take us one step closer 
to understanding the personalized responses to acute alcohol consumption and the perceived epigenetic changes 
that are induced. All in all, we concur that acute alcohol consumption studies broaden insights on significant 
adverse health effects of alcohol even in healthy individuals42. These insights will help researchers to define novel 
approaches to treat or ameliorate alcohol-induced disability, organ damage and morbidity.
Materials and Methods
Intervention study design. The experimental group consisted of 12 clinically selected healthy males (aged 
20–24 years), who admitted to consuming alcohol at a moderate, social level (baseline alcohol consumption was 
defined by the participants’ declared levels of drinking). None of the participants used any medication. They 
were asked to refrain from vitamins, minerals, and other supplementation, and to follow a similar dietary and 
lifestyle pattern for the duration of the study. The experimental interventions were performed at the Health Clinic 
of North-West University under controlled conditions. A medical doctor and nurse were present during the 
period of intervention, and all participants could leave the premises only after approval by the medical doctor. 
The protocol was approved by the Health Sciences Ethical Committee of North-West University (ethical approval 
number: NWU-00045-12-S1), conducted in accordance with guidelines for good clinical practice, and all partic-
ipants provided informed written consent to the research protocol (an example of the informed consent form is 
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included in section 5 of the SI). The protocol was registered as a clinical trial on 3 November 2017 under the Pan 
African Clinical Trial Registry (registration number: PACTR201711002748255), under the title: A metabolomics 
investigation on experimental interventions of acute alcohol consumption.
The experiments were conducted on two Saturday mornings between 08:00 and 12:00. All participants were 
required to abstain from alcohol consumption for at least 48 hours preceding the experiment, and to abstain from 
breakfast on the days of the experiments (that is, to remain in an overnight fasted state). On the first Saturday, 
half of the participants (randomly selected) were given 500 mL lemon-flavoured sparkling water as vehicle only 
(contents: fructose and citric acid flavouring; sodium benzoate preservative; sodium cyclamate, aspartame, ace-
sulfame K sweeteners; vitamin C). The other half of the participants received the same quantity of the vehicle, 
as well as a predefined quantity of alcohol — 1.5 mL alcohol per kilogram body mass69. The alcohol used was 
triple-distilled vodka: 43% alcohol. On the second Saturday, the participants received the alternate intervention to 
the one received on the first Saturday. On both days the participants were also provided with 1.5 L bottled water, 
which was the only substance that could be consumed over the 4-hour period of the experiment. Differences in 
the concentrations of urinary metabolites due to variation in water consumption between the participants were 
accounted for by determining the creatinine concentration of each sample, and expressing the concentrations of 
all the quantified metabolites as μmol metabolite/mmol creatinine. Initial (time 0) urine samples were collected 
just prior to the intervention. Subsequent urine samples were collected at 1, 2, 3 and 4 hours after the start of the 
experiment. This gave a total of five urine samples from each participant for each intervention. Time 0 urine sam-
ples served as controls for each participant, with longitudinal data being compared accordingly.
Sample handling. After collection, each urine sample was divided into aliquots and stored at −80 °C. Once 
all the urine samples had been collected, a 1 mL aliquot of each sample was thawed and combined to prepare a 
pooled quality control (QC) sample. This QC sample was divided into aliquots and once again stored at –80 °C. 
Another 1 mL aliquot of each urine sample was used for creatinine determination, performed by an external 
pathology service.
Metabolomics workflow. The workflow of the intervention study (Fig. 6) started with the generation of 
time-dependent quantitative metabolomics data, progressed to the application of various models of statistical 
analysis, which eventually led to the biological interpretation of the effect of the interventions on the group as well 
as on individual cases. The samples collected prior to alcohol (or vehicle) consumption were used as controls for 
the subsequent hourly samples collected after the interventions. The effect of the vehicle-only intervention was 
previously described35, and will not be discussed here.
Measurement design. For the generation of data through GC–MS analysis, each participant’s samples were 
analysed in a separate batch. Each batch included the participant’s 10 urine samples (S), repeat samples (R) and 
quality control samples (Q), and each batch was constructed and analysed as follows:
Figure 6. Representation of the metabolomics workflow to investigate the effect of acute alcohol consumption. 
(a) Longitudinal data were generated through the GC–MS analyses for 120 metabolites across five hourly 
intervals. (b) Two metabolic states — before alcohol consumption (time 0) and after alcohol consumption 
(times 1 to 4 hours) — were compared through multivariate, as well as univariate, analyses to establish the 
levels of significance of the observed differences. (c) Correlation analysis was used to indicate the relationship 
between important metabolites. (d) Unfolded PCA was applied to the data that emerged in time to summarize 
the subsequent variability, and, more importantly, between individuals, due to the alcohol effect, as well as for 
the identification of the metabolites responsible for this variability. (e) Construction of a global metabolite 
profile from the combined results provided the framework for the discussion on the effects of acute alcohol 
consumption on the subjects’ metabolism.
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where:
Q  = Quality control sample  [Total = 11]
SV  = Randomly selected vehicle sample  [Total = 5]
SA  = Randomly selected alcohol sample  [Total = 5]
RA  = Randomly selected alcohol repeat sample  [Total = 2]
RV  = Randomly selected vehicle repeat sample  [Total = 2].
QC samples were included to estimate any batch effect or other interfering analytical aspects. The data from 
the five QC samples at the start of each batch were used to condition the column and were excluded from further 
analysis. Repeat samples were included to determine their repeatability across the batch — the first two repeat 
samples in each batch were repeats of experimental samples from later in the batch, and the last two repeat sam-
ples were repeats of experimental samples from earlier in the batch. The total GC–MS running time for each batch 
was approximately 21 hours.
Organic acid extraction and GC–MS analysis. A 5 mL aliquot of each urine sample was used for organic 
acid extraction before GC–MS analysis, as described previously70. All experimental, QC and repeat samples were 
prepared and derivatized individually and in the same way. Full details of the method are presented in section 1 
of the SI. An excerpt of the data used for the alcohol intervention is shown in Supplementary Table S1 (section 
2 of the SI). Metabolite concentrations are expressed as µmol/mmol creatinine relative to an internal standard 
(4-phenylbutyric acid).
Quantitative urinary alcohol excretion. Urinary ethanol is not detectable by the GC–MS method used 
here due to its high volatility, but was quantified in all samples obtained from the vehicle and alcohol interven-
tions by means of NMR spectroscopy. The data indicated that ethanol excretion peaked at 2 hours following 
alcohol consumption (data not shown).
Variable identification, classification and reduction. The QC samples were used to identify and clas-
sify a list of representative variables in all the urine samples. Following untargeted GC–MS data generation, a total 
of 172 variables were detected through AMDIS, excluding the 2 internal standards used. Several of the variables 
were present in concentrations just above the detection limit, and were not observed in all QC samples. The 
Human Metabolome Database (www.hmdb.ca) was used as the reference for the biological description of each 
feature, and as the basis for classifying the variables. Information on variables not included in the HMDB (e.g. 
exogenous substances or artifacts formed during the derivatization reactions) was obtained from other estab-
lished chemical databases or from the literature; failure with this resulted in the classification of 7 variables as “no 
annotation”. Details of the 172 variables are summarized in Supplementary Table S2, and exclusion criteria for the 
determination of metabolite relevance are described in section 3 of the SI. From this protocol, 120 metabolites 
were identified and used for the statistical evaluation of the effect of alcohol consumption.
Statistical analysis. Identification of important organic acid metabolites. Metabolites causing the sep-
arations were regarded as important if they varied substantially between the samples collected prior to alco-
hol consumption and those collected one hour after alcohol consumption. Changes in metabolite levels were 
ranked based on their multivariate VIP values (Variable Importance in Projection), fold change (FC) values and 
non-parametric Wilcoxon signed-rank test (WRT) p-values. The selection criteria were: VIP ≥ 1.0, WRT p ≤ 0.05 
and |FC| ≥ 1.5. The aim with the selection was for a deeper understanding of the dominant biological changes 
rather than to model the observed data.
Multivariate statistical analysis. Two modes of multivariate statistical analyses were applied to the 
metabolomics data generated during this intervention experimental design: (1) cross-sectional analysis of time 
points using traditional multivariate methods to compare two groups (PCA and PLS-DA); and (2) longitudinal 
analysis performed across all times (ASCA34,71 and unfolded PCA72). Details of these methods were previously 
described35.
The statistical analyses indicated that we should achieve acceptable power (0.8) for a large effect size (0.9) 
given 12 paired observations and a 5% significance level. We should therefore be able to identify large differ-
ences between two factor levels (that is, between two points in time or two interventions) for a single variable 
(see SI section 4.1 for details). Prior to statistical analysis, the data were pre-processed by: (i) treatment of 
zero-valued observation; and (ii) transformation and scaling. This is explained in greater detail in section 4.2 
of the SI. PCA was used to project the observed data to new spaces that maximizes the variation along fewer 
hyperplanes while not taking the group membership into consideration. PLS–DA was applied to build models 
to predict group membership, by projecting the variance in the observed data measured and the membership 
to new spaces. PLS–DA was used as a supervised method to rank and select the metabolites most changed 
by the intervention. The significance of these changes was established through univariate analysis using the 
Wilcoxon signed-rank test and fold change ratios. The figures shown in Fig. 1 do not take into account the 
paired nature of the data. However, multi-level PCA and PLS–DA were also performed, which cater specifically 
for repeated measures. The multi-level results are closely related to those reported here, and are included in 
sections 4.3 and 4.5 of the SI.
Data availability. The full data set is given in Excel format as part of the SI (available online).
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